<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Vegetarian nutrition (VN) evidence based nutrition practice guideline.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Academy of Nutrition and Dietetics. Vegetarian nutrition (VN) evidence based nutrition guideline. Chicago (IL): Academy of Nutrition and Dietetics; 2011 Sep. Various p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="ICD9CM: Diabetes with other coma, type II or unspecified type, not stated as uncontrolled  (250.30); Eating disorder, unspecified  (307.50); Obesity, unspecified  (278.00); Overweight  (278.02)"/><FieldValue Value="MSH: Adolescent Nutritional Physiological Phenomena ; Blood Cell Count ; Blood Chemical Analysis ; Child Nutritional Physiological Phenomena ; Counseling ; Diabetes Mellitus, Type 2 ; Diet Therapy ; Diet, Vegetarian ; Dietary Proteins ; Dietary Supplements ; Docosahexaenoic Acids ; Eating Disorders ; Eicosapentaenoic Acid ; Fatty Acids, Essential ; Folic Acid ; Health Knowledge, Attitudes, Practice ; Hyperlipidemias ; Maternal Nutritional Physiological Phenomena ; Micronutrients ; Nutrition Assessment ; Nutrition Therapy ; Nutritional Physiological Phenomena ; Nutritional Status ; Obesity ; Overweight ; Patient Compliance ; Plant Proteins ; Pregnancy ; Prenatal Nutritional Physiological Phenomena ; Vitamin B 12 ; Vitamin B 12 Deficiency ; Vitamins "/><FieldValue Value="MTH: blood cell count ; Blood Chemical Analysis ; complete blood count ; Compliance behavior ; Counseling ; Diabetes Mellitus, Non-Insulin-Dependent ; Diet education ; Diet therapy ; Dietary Supplements ; docosahexaenoic acid ; Docosahexaenoic Acids ; Eating Disorders ; Eicosapentaenoic Acid ; Folic Acid ; Health Knowledge, Attitudes, Practice ; Hyperlipidemia ; Iron deficiency ; Macronutrient ; Micronutrients ; Nutrition Assessment ; Nutrition management ; Nutrition Therapy ; Nutritional status ; Obesity ; OVERWEIGHT ; Pregnancy ; REGISTERED DIETICIAN ; Serum ferritin measurement ; Serum iron measurement ; Serum transferrin measurement ; Serum vitamin B12 measurement ; Serum vitamin D measurement ; Serum zinc measurement ; Vegetarian diet ; Vitamin B 12 ; VITAMIN B 12 DEFICIENCY ; Vitamin supplementation ; Vitamins "/><FieldValue Value="PDQ: cyanocobalamin ; folic acid ; obesity "/><FieldValue Value="SNOMEDCT_US: Assessment of nutritional status  (1759002); Assessment of nutritional status  (310243009); Blood cell count  (88308000); Blood chemistry  (166312007); Child nutrition  (87346005); Cobalamin deficiency  (190634004); Complete blood count  (26604007); Compliance behavior  (405078008); Counseling  (129441002); Counseling  (409063005); Deficiency of micronutrients  (238111008); Diet education  (11816003); Docosahexaenoic acid  (226368001); Eating disorder  (72366004); Eicosapentaenoic acid  (226367006); Folic acid  (6247001); Folic acid  (63718003); Health knowledge measurement  (304733008); Hyperlipidemia  (55822004); Iron deficiency  (35240004); Lacto-vegetarian diet  (6228004); Nutrition management  (386372009); Nutrition therapy  (386373004); Nutritional status  (87276001); Nutritional supplement  (108961000); Nutritional supplement  (226279009); Nutritional supplement  (373453009); Obesity  (414915002); Obesity  (414916001); Overweight  (238131007); Ovo-lacto-vegetarian  (162538009); Pregnancy  (289908002); Serum ferritin measurement  (269821003); Serum free fatty acid measurement  (313556000); Serum iron measurement  (250216004); Serum vitamin B12 measurement  (271216009); Serum vitamin D measurement  (270990000); Serum zinc measurement  (273975003); Therapeutic diets  (226077000); Type 2 diabetes mellitus  (44054006); Vegetarian diet  (5940000); Vegetarian diet education  (183070000); Vegetarian food intake  (230108008); Vitamin  (12968008); Vitamin  (87708000); Vitamin B>12< preparation  (30010009); Vitamin B>12< preparation  (419382002); Vitamin B>12< preparation  (81064004); Vitamin supplementation  (226314006); Zinc deficiency  (238124008)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Vegetarian lifestyle &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Hyperlipidemia &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Overweight or obesity &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Type 2 diabetes &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Disordered eating behavior &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Pregnancy &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Counseling" /><FieldValue Value="Evaluation" /><FieldValue Value="Management" /><FieldValue Value="Prevention" /><FieldValue Value="Treatment" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Cardiology" /><FieldValue Value="Endocrinology" /><FieldValue Value="Family Practice" /><FieldValue Value="Internal Medicine" /><FieldValue Value="Nutrition" /><FieldValue Value="Obstetrics and Gynecology" /><FieldValue Value="Pediatrics" /><FieldValue Value="Preventive Medicine" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Advanced Practice Nurses" /><FieldValue Value="Dietitians" /><FieldValue Value="Health Care Providers" /><FieldValue Value="Nurses" /><FieldValue Value="Physician Assistants" /><FieldValue Value="Physicians" /><FieldValue Value="Students" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Overall Objective&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;To provide medical nutrition therapy (MNT) guidelines for individuals who follow or are interested in following a vegetarian dietary lifestyle.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Specific Objectives&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;To define evidence-based vegetarian nutrition recommendations for&amp;nbsp;registered dietitians (RDs) that are carried out in collaboration with other healthcare providers &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To guide practice decisions that integrate medical, nutritional and behavioral strategies into the overall medical management of people choosing or interested in a vegetarian dietary pattern &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To reduce variations in practice among RDs &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To provide RDs with data and insight to make recommendations to adjust MNT or recommend other therapies and strategies to achieve desired outcomes for treatment or prevention of disease &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To enable RDs to help individuals identify dietary choices that not only support their clients' moral, ethical or religious views, but promote optimal health as well &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To provide evidence-based findings to aid RDs in the design of healthy flesh-free and animal-free diets that meet the needs and interests of a broad range of individuals &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To provide resources, derived from a systematic review of research, for RDs to enable their clients to make healthful vegetarian dietary choices &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To promote self-management strategies that empower the patient to take responsibility for day-to-day management and provide RDs with data to make recommendations to adjust MNT or to recommend other therapies to achieve clinical outcomes &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To enhance the quality of life for individual vegetarians, utilizing customized strategies based on the individual's preferences, lifestyle and goals &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To develop content for interventions that can be tested on clinical outcomes &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To define the highest quality of care within cost constraints of the current healthcare environment &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Children (2 to 12 years), adolescents (13 to 18 years), and adults (including pregnant adults and adolescents) who follow or are interested in following a vegetarian dietary pattern&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Evaluation (Nutrition Assessment)&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Nutrition assessment including macronutrient (particularly protein) intake; micronutrient intake (particularly folate, vitamin B-12, iron, and zinc); essential fatty acid intake &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Assessment of knowledge, beliefs, and motivations about a vegetarian diet and signs of disordered eating behavior &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Biochemical data and relevant laboratory values, including complete blood count (CBC), serum iron, ferritin, transferrin, vitamin B-12 (methylmalonic acid levels), zinc, vitamin D, and essential fatty acids (EFA) &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Management/Treatment&lt;/strong&gt; &lt;strong&gt;(Nutrition Interventions)&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Treating hyperlipidemia, overweight/obesity, or type 2 diabetes with a vegetarian diet &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nutrition prescription to ensure the Dietary Reference Intakes (DRI) for all micronutrients are met &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nutrition prescription to ensure vitamin B-12 requirements are met by diet and/or supplementation, including prenatal supplements &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nutrition counseling to support therapeutic vegetarian diet &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Education on diet diversity and, when appropriate, vitamin and mineral supplements &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nutrition prescription for protein intake from a variety of plant sources &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Counseling on increasing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) intake if EFA levels are low or sub-optimal &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Monitoring for adherence to therapeutic diet &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Micronutrient, protein, and fatty acid needs in vegetarians &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Effectiveness of vegetarian diet in treating obesity, hyperlipidemia, and type 2 diabetes &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Hand-searches of Published Literature (Primary Sources)" /><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;General Methods for Collecting/Selecting the Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The following list provides an overview of the steps which the Academy evidence analysis team goes through to identify research through database searches.&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Plan the search strategy&lt;/strong&gt; to identify the &quot;current best evidence&quot; relevant to the question. The plan for identification and inclusion of articles and reports should be systematic and reproducible, not haphazard. Write out the original search strategy and document adjustments to the strategy if they occur. Allow for several iterations of searches. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;List inclusion and exclusion criteria&lt;/strong&gt;. The work group will define the inclusion and exclusion criteria. These criteria will be used in defining the search strategy and for filtering the identified research reports. The Academy uses only peer-reviewed research; that is, articles accepted for evidence analysis must be peer-reviewed and published in a juried publication. Additionally, the Academy only uses human subjects in its research and does not include animal studies in its evidence analysis. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Identify search words&lt;/strong&gt;. During the process of considering outcomes, interventions, nutrition diagnoses, and assessments, the work group may have identified a number of specific terms or factors that were important, but were not included in the actual question. These terms can be used as additional search terms to help identify relevant pieces of research. Both text word search and keyword search using Medical Subject Headings (MeSH) definitions may be used. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Identify databases to search&lt;/strong&gt;. PubMed, Medline, CINAHL, EMBASE, Cochrane, Agricola, DARE, TRIP, AHRQ and ERIC are some common databases for clinical nutritional research. Note that search terms can vary depending on the database. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Conduct the search&lt;/strong&gt;. Depending on the number and type of sources found in the initial search, adjustments might have to be made in the search strategy and to inclusion/exclusion criteria, and additional searches run. Changes to the search plan should be recorded for future reference. Document the number of sources identified in each search. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Review titles and abstracts&lt;/strong&gt;. At this point, a filtering procedure is used to determine whether a research article matches the inclusion criteria and is relevant to the work group's questions. Typically, the lead analyst, along with a member of the expert workgroup, first reviews the citations and abstracts to filter out reports that are not applicable to the question. If a determination cannot be made based on the citation and abstract, then the full text of the article is obtained for review. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Gather all remaining articles and reports&lt;/strong&gt;. Obtain paper or electronic copies of research articles that remain on the list following the citation and abstract review. If there are less than six citations, it could mean that the search was too specific to identify relevant research or that research has not been done on this topic. A broadened search should be tried. When there is a long list of citations, ascertain whether it includes articles that are tangential to the question or address the question in only a general way. In this case a more focused search strategy may be necessary. &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Specific Methods for This Guideline&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The recommendations in the guideline were based on a systematic review of the literature. Searches of PubMed, EBSCO host: Academic Search Premier, and CENTRAL databases and Agency for Healthcare Research and Quality (AHRQ) Evidence Reports and hand searches of other relevant literature were performed on the following topics:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Types and diversity of vegetarian diets &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Vegetarian nutrition and nutrients&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Vegetarian nutrition and micronutrients &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Vegetarian nutrition and macronutrients &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Vegetarian nutrition in the lifecycle&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Vegetarian nutrition in childhood and adolescence &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Vegetarian nutrition in pregnancy &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Vegetarian nutrition and chronic diseases&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Vegetarian nutrition and cardiovascular disease &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Vegetarian nutrition and obesity &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Vegetarian nutrition and type 2 diabetes &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Therapeutic diets and attrition &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Each evidence analysis topic has a link to supporting evidence in the original guideline, where the Search Plan and Results can be found. Here the reader can view when the search plan was performed, specific inclusion and exclusion criteria, search terms, data bases that were searched, and the excluded articles.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Conclusion Grading Table&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Conclusion Grading Table&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Strength of Evidence Elements&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade I&lt;br /&gt;&#xD;&#xA;            Good/Strong&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade II&lt;br /&gt;&#xD;&#xA;            Fair&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade III&lt;br /&gt;&#xD;&#xA;            Limited/Weak&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade IV&lt;br /&gt;&#xD;&#xA;            Expert Opinion Only&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade V&lt;br /&gt;&#xD;&#xA;            Grade Not Assignable&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Quality&lt;/strong&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Scientific rigor/validity &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Considers design and execution &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studies of strong design for question&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Free from design flaws, bias and execution problems &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studies of strong design for question with minor methodological concerns&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Only studies of weaker study design for question&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studies of weak design for answering the question&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Inconclusive findings due to design flaws, bias or execution problems&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;No studies available&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Conclusion based on usual practice, expert consensus, clinical experience, opinion, or extrapolation from basic research &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;No evidence that pertains to question being addressed &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Consistency&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Of findings across studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Findings generally consistent in direction and size of effect or degree of association, and statistical significance with minor exceptions at most&lt;/td&gt;&#xD;&#xA;            &lt;td style=&quot;text-align: left; vertical-align: top;&quot;&gt;Inconsistency among results of studies with strong design&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Consistency with minor exceptions across studies of weaker designs&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Unexplained inconsistency among results from different studies&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Single study unconfirmed by other studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Conclusion supported solely by statements of informed nutrition or medical commentators&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;NA&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Quantity&lt;/strong&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Number of studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Number of subjects in studies &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;One to several good quality studies&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Large number of subjects studied&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Studies with negative results having sufficiently large sample size for adequate statistical power&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Several studies by independent investigators&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Doubts about adequacy of sample size to avoid Type I and Type II error &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Limited number of studies&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Low number of subjects studied and/or inadequate sample size within studies &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Unsubstantiated by published studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Relevant studies have not been done&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Clinical Impact&lt;/strong&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Importance of studied outcomes &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Magnitude of effect &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studied outcome relates directly to the question&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Size of effect is clinically meaningful&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Significant (statistical) difference is large &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Some doubt about the statistical or clinical significance of effect&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studied outcome is an intermediate outcome or surrogate for the true outcome of interest&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Size of effect is small or lacks statistical and/or clinical significance&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Objective data unavailable&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Indicates area for future research&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Generalizability&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            To population of interest&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studied population, intervention and outcomes are free from serious doubts about generalizability&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Minor doubts about generalizability&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Serious doubts about generalizability due to narrow or different study population, intervention or outcomes studied&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Generalizability limited to scope of experience&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;NA&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;This grading system was based on the grading system from Greer, Mosser, Logan, &amp;amp; Wagstrom Halaas. A practical approach to evidence grading. Jt Comm J Qual Improv. 2000;26:700-712. &lt;a href=&quot;http://www.adaevidencelibrary.com/topic.cfm?cat=1330&quot; title=&quot;AND Web site&quot;&gt;http://www.adaevidencelibrary.com/topic.cfm?cat=1330&lt;/a&gt;. In September 2004, The ADA Research Committee modified the grading system to this current version.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Systematic Review with Evidence Tables" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Step 1: Formulate Evidence Analysis Question&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Specify a question in a defined area of practice; or state a tentative conclusion or recommendation that is being considered. Include the patient type and special needs of the target population involved, the alternatives under consideration, and the outcomes of interest (PICO format).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Step 2: Gather and Classify Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Conduct a systematic search of the literature to find evidence related to the question, gather studies and reports, and classify them by type of evidence. Classes differentiate primary reports of new data according to study design, and distinguish them from secondary reports that include systematic and/or narrative review.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Step 3: Critically Appraise Each Article&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Review each article for relevance to the question and use the checklist of questions to evaluate the research design and implementation. Abstract key information from the report.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Step 4: Summarize Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Synthesize the reports into an overview table and summarize the research relevant to the question.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Step 5: Write and Grade the Conclusion Statement&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Develop a concise conclusion statement (the answer to the question). Assign a grade to indicate the overall strength or weakness of evidence informing the conclusion statement (see the &quot;Rating Scheme for the Strength of the Evidence&quot; field).&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Moving from Analysis to the Evidence-Based Nutrition Practice Guideline&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The expert workgroup, which includes practitioners and researchers with a depth of experience in the specific field of interest, develops the disease-specific guideline. The guideline development involves the following steps.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Review the Conclusion Statements&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The workgroup meets to review the materials resulting from the evidence analysis, which may include review of the conclusion statements, evidence summaries and evidence worksheets.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Formulate Recommendations for the Guideline Integrating Conclusions from Evidence Analysis&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The workgroup uses an expert consensus method to formulate the guideline recommendations and complete the various sections on the recommendation page. These include:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Recommendation(s)&lt;/strong&gt;: This is a course of action for the practitioner. The recommendation is written using two brief and separate statements. The first statement is &quot;what&quot; the dietitian should do or not do? The second statement describes the &quot;why&quot; of the recommendation. More than one recommendation may be formulated depending on a particular topic and the supporting conclusion statements. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Rating&lt;/strong&gt;: The rating for the recommendation is based on the strength of the supporting evidence. The grade of the supporting conclusion statement(s) will be help determining this rating (see the &quot;Rating Scheme for the Strength of the Recommendations&quot; field). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Label of Conditional or Imperative&lt;/strong&gt;: Each recommendation will have a label of &quot;conditional&quot; or &quot;imperative&quot;. Conditional statements clearly define a specific situation, while imperative statements are broadly applicable to the target population without restraints on their pertinence. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Risks and Harms of Implementing the Recommendation&lt;/strong&gt;: Includes any potential risks, anticipated harms or adverse consequences associated with applying the recommendation(s) to the target population. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Conditions of Application&lt;/strong&gt;: Includes any organizational barriers or changes that would need to be made within an organization to apply the recommendation in daily practice. Also includes any conditions which may limit the application of the recommendation(s). For instance, application may be limited to only people in an inpatient setting, or not applicable for pregnant women. Conditional recommendations will always have conditions specified. Imperative recommendations may have some general conditions for application. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Potential Costs Associated with Application&lt;/strong&gt;: Includes any costs that may be associated with the application of this recommendation such as specialized staff, new equipment or treatments. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Recommendation Narrative&lt;/strong&gt;: Provides a brief description of the evidence that supports this recommendation. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;: Provides a brief list of the evidence strength and methodological issues that determined the recommendation strength. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Minority Opinions&lt;/strong&gt;: If the expert work group cannot reach consensus on the recommendation, the minority opinions may be listed here. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Supporting Evidence&lt;/strong&gt;: Provides links to the conclusions statements, evidence summaries and worksheets related to the formulation of this recommendation(s). &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;References Not Graded in the Academy's Evidence Analysis Process&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Recommendations are based on the summarized evidence from the analysis. Sources that are not analyzed during the evidence analysis process may be used to support and formulate the recommendation or to support information under other categories on the recommendation page, if the workgroup deems necessary. References must be credible resources (e.g., consensus reports, other guidelines, position papers, standards of practice, articles from peer-reviewed journals, nationally recognized documents or websites). If recommendations are based solely on these types of references, they will be rated as &quot;consensus.&quot;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Occasionally recommendations will include references that were not reviewed during the evidence analysis process but are relevant to the recommendation, risks and harms of implementing the recommendation, conditions of application, or potential costs associated with application. These references will be listed on the recommendation page under &quot;References Not Graded in the Academy's Evidence Analysis Process.&quot;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Develop a Clinical Algorithm for the Guideline&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The workgroup develops a clinical algorithm based on Academy's Nutrition Care Process, to display how each recommendation can be used within the treatment process and how they relate to the Nutrition Assessment, Diagnosis, Intervention and Monitoring and Evaluation.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Complete the Writing of the Guideline&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Each disease-specific guideline has a similar format which incorporates the Introduction (includes: Scope of the Guideline, Statement of Intent, Guideline Methods, Implementation, Benefits and Risks/Harms of Implementation), Background Information and any necessary Appendices. The workgroup develops these features.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Criteria Used in Guideline Development&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The criteria used in determining the format and process for development of the Academy's guidelines is based on the following tools and criteria for evidence-based guidelines:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Guideline Elements Model (GEM) which has been incorporated by the American Society for Testing and Materials (ASTM) as a Standard Specification for clinical practice guidelines. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;AGREE (Appraisal for Guidelines Research and Evaluation) Instrument &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;National Guideline Clearinghouse &lt;a href=&quot;http://www.guideline.gov&quot; title=&quot;NGC Web site&quot; target=&quot;_blank&quot;&gt;www.guideline.gov&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Criteria for Recommendation Rating&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Criteria for Recommendation Rating&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Statement Rating&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Definition&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Implication for Practice&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Strong&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Strong&lt;/strong&gt; recommendation means that the workgroup believes that the benefits of the recommended approach clearly exceed the harms (or that the harms clearly exceed the benefits in the case of a strong negative recommendation), and that the quality of the supporting evidence is excellent/good (grade I or II).* In some clearly identified circumstances, strong recommendations may be made based on lesser evidence when high-quality evidence is impossible to obtain and the anticipated benefits strongly outweigh the harms. &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should follow a &lt;strong&gt;Strong&lt;/strong&gt; recommendation unless a clear and compelling rationale for an alternative approach is present. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Fair&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Fair&lt;/strong&gt; recommendation means that the workgroup believes that the benefits exceed the harms (or that the harms clearly exceed the benefits in the case of a negative recommendation), but the quality of evidence is not as strong (grade II or III).* In some clearly identified circumstances, recommendations may be made based on lesser evidence when high-quality evidence is impossible to obtain and the anticipated benefits outweigh the harms.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should generally follow a &lt;strong&gt;Fair&lt;/strong&gt; recommendation but remain alert to new information and be sensitive to patient preferences.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Weak&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Weak&lt;/strong&gt; recommendation means that the quality of evidence that exists is suspect or that well-done studies (grade I, II, or III)* show little clear advantage to one approach versus another.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should be cautious in deciding whether to follow a recommendation classified as &lt;strong&gt;Weak&lt;/strong&gt;, and should exercise judgment and be alert to emerging publications that report evidence. Patient preference should have a substantial influencing role. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Consensus&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Consensus&lt;/strong&gt; recommendation means that Expert opinion (grade IV) supports the guideline recommendation even though the available scientific evidence did not present consistent results, or controlled trials were lacking.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should be flexible in deciding whether to follow a recommendation classified as &lt;strong&gt;Consensus&lt;/strong&gt;, although they may set boundaries on alternatives. Patient preference should have a substantial influencing role. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Insufficient Evidence&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;An &lt;strong&gt;Insufficient Evidence&lt;/strong&gt; recommendation means that there is both a lack of pertinent evidence (grade V)* and/or an unclear balance between benefits and harms.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should feel little constraint in deciding whether to follow a recommendation labeled as &lt;strong&gt;Insufficient Evidence&lt;/strong&gt; and should exercise judgment and be alert to emerging publications that report evidence that clarifies the balance of benefit versus harm. Patient preference should have a substantial influencing role.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*Conclusion statements are assigned a grade based on the strength of the evidence. Grade I is good; grade II, fair; grade III, limited; grade IV signifies expert opinion only and grade V indicates that a grade is not assignable because there is no evidence to support or refute the conclusion. The evidence and these grades are considered when assigning a rating (Strong, Fair, Weak, Consensus, Insufficient Evidence - see chart above) to a recommendation.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Adapted by the Academy of Nutrition and Dietetics (AND) from the American Academy of Pediatrics, Classifying Recommendations for Clinical Practice Guideline, Pediatrics. 2004;114;874-877. Revised by the AND Evidence-Based Practice Committee, Feb 2006.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="External Peer Review" /><FieldValue Value="Internal Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Each guideline is reviewed internally and externally using the AGREE (Appraisal of Guidelines for Research and Evaluation) Instrument as the evaluation tool. The external reviewers consist of an interdisciplinary group of individuals (may include dietitians, doctors, psychologists, nurses, etc.). The guideline is adjusted by consensus of the expert panel and approved by Academy's Evidence-Based Practice Committee prior to publication on the Evidence Analysis Library (EAL).&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Ratings for the strength of the recommendations (Strong, Fair, Weak, Consensus, Insufficient Evidence), conclusion grades (I-V), and statement labels (Conditional versus Imperative) are defined at the end of the &quot;Major Recommendations&quot; field.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Vegetarian Nutrition (VN): Assessing Food and Nutrient Intake of Child and Adolescent Vegetarians&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Micronutrient Intake of Adolescent Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adolescent vegetarians, the registered dietitian (RD) should assess micronutrient intake, particularly iron, zinc, vitamin C and vitamin B-12. Research from a limited number of Western countries indicates that adolescent vegetarians or semi-vegetarians (11 to 19 years) may have lower intake than national standards for micronutrients such as iron, zinc and vitamin C. In addition, two studies measuring methylmalonic acid (MMA) levels showed that lacto-ovo vegetarian/lacto-vegetarian (LOV/LV) or omnivorous adolescents (9 to 15 years) who had followed a very restrictive vegetarian diet (macrobiotic) early in life, may be at risk for vitamin B-12 deficiency (41% of adolescents had MMA &amp;gt;290nmol/L and 21% had MMA &amp;gt;410nmol/L).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Dietary Intake of Adolescent Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adolescent vegetarians, the RD should assess intake of foods rich in calcium (e.g., dairy products, kale, broccoli, fortified soy milk, etc.). Research indicates that although dietary patterns differ among countries, adolescent vegetarians (11 to 19 years) tended to consume fewer dairy products.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Micronutrient Intake of Vegetarian Children&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For vegetarian children, the RD should assess micronutrient intake, particularly vitamin B-12. Research studies measuring MMA levels indicate that small children (10 months to 11.7 years) of parents who follow a macrobiotic diet, had a high prevalence of vitamin B-12 deficiency (55% to 85%).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Weak&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Macronutrient Intake of Child and Adolescent Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For child and adolescent vegetarians, the RD should assess intake of protein and essential fatty acids (EFA). While meeting protein requirements is typically not an issue with vegetarian diets, the RD can recommend that children and adolescents include complementary mixtures of plant proteins. This can be achieved by consuming a varied diet throughout the day. In addition, some research suggests that blood and tissue eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) levels may be sub-optimal among patients who follow a vegetarian dietary pattern.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Consensus&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades II, III, and Consensus&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Assessing Knowledge, Beliefs and Motivations of Adult, Child and Adolescent Vegetarians&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Knowledge and Beliefs of Adult, Child and Adolescent Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adult, child and adolescent vegetarians, the RD should assess knowledge and beliefs about a vegetarian diet. Research indicates that vegetarian dietary patterns vary and fluctuate over time. Even within types of vegetarian diets, individuals may not always include a variety of healthful foods in their diet. Vegetarians who are on highly restrictive diets resulting from unhealthful food choices may be at nutritional risk. Specific nutrient considerations may need to be addressed in some vegetarian dietary patterns for optimal nutrition.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Motivations That Influence Vegetarian Dietary Lifestyle for Adults and Children&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adult, child and adolescent vegetarians, the RD should assess reasons for following a vegetarian lifestyle. Research indicates that the motivations for being vegetarian (e.g., health, ethical, environmental, cultural or religious, etc.) influence dietary practices which may impact nutrient intake. Dietary patterns based on health beliefs may be more flexible than dietary patterns based on religious or moral convictions.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades I and II&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Assessing for Signs of Disordered Eating Behaviors Among Adolescent and Young Adult Vegetarians&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing for Signs of Disordered Eating Behaviors Among Adolescent and Young Adult Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In adolescent and young adult (19 to 30 years) vegetarians, the RD should assess for problem behaviors such as dieting. Research finds that a subset of vegetarian adolescents and young adults shows higher patterns of unhealthful dieting practices than omnivores or more health conscious vegetarians of the same age.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Fair&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statement is &lt;strong&gt;Grade II&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Assessing Biochemical Data of Adult, Child and Adolescent Vegetarians&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Biochemical Data of Adult, Child and Adolescent Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adult, child and adolescent vegetarians for whom dietary assessment reveals inadequate intake, the RD should assess the biochemical data, medical tests and procedures including, but not limited to complete blood count (CBC), serum iron, ferritin, transferrin, vitamin B-12, zinc, vitamin D, and EFA. Research suggests that intake and/or bioavailability of these nutrients may be of special concern for vegetarian or vegan adults, adolescents and children. Assessment of these factors is needed to effectively determine nutrition diagnoses and plan the nutrition interventions. Inability to achieve optimal nutrient intake may contribute to poor outcomes.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Consensus&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Vitamin B-12 Status of Adult, Child and Adolescent Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adult, child and adolescent vegetarians, the RD should assess for dietary adequacy of vitamin B-12 intake. If dietary intake of vitamin B-12 is inadequate, then the RD may recommend using MMA if available, as a functional indicator of deficiency. Two research studies measuring MMA levels showed that LOV/LV or omnivorous adolescents (9 to 15 years) who had followed a very restrictive vegetarian diet (macrobiotic) early in life, may be at risk for vitamin B-12 deficiency (41% of adolescents had MMA &amp;gt;290nmol/L and 21% had MMA &amp;gt;410nmol/L). In addition, research studies showed that the prevalence of vitamin B-12 deficiency among healthy, non-pregnant adult vegetarians ranged from 30% to 86%. When vegans and LOV/LV vegetarians were analyzed separately, vegans had even higher proportions of vitamin B-12 deficiency (43% to 88%). Among children (10 months to 11.7 years) and older adults (&amp;gt;55 years), the prevalence of vitamin B-12 deficiency was 55% to 85% and 46.9% to 68%, respectively.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Fair&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades I, III, and Consensus&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Assessing Food and Nutrient Intake of Adult Vegetarians&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Micronutrient Intake of Adult Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adult vegetarians, the RD should assess micronutrient intake, particularly vitamin B-12. Research studies measuring MMA levels showed that the prevalence of vitamin B-12 deficiency among healthy, non-pregnant adult vegetarians ranged from 30% to 86%. When vegans, LOV/LV were analyzed separately, vegans had even higher proportions of vitamin B-12 deficiency (43% to 88%). Among older adults (&amp;gt;55 years), the prevalence of vitamin B-12 deficiency was 46.9% to 68%.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Fair&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Protein Intake of Adult Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adult vegetarians, the RD should assess intake of protein. While meeting protein requirements is typically not an issue with vegetarian diets, the RD can recommend that adults include complementary mixtures of plant proteins. This can be achieved by consuming a varied diet throughout the day.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Consensus&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Essential Fatty Acid Intake of Adult Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adult vegetarians, the RD should assess dietary intake of EFA. Some research suggests that blood and tissue EPA and DHA levels may be sub-optimal among patients who follow a vegetarian dietary pattern.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Consensus&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades I, III, and Consensus&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Assessing Food and Nutrient Intake During Pregnancy for Adolescent and Adult Vegetarians&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Micronutrient Needs in Pregnant Adolescent and Adult Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For pregnant adolescent and adult vegetarians, the RD should assess the patient's/client's intake of all micronutrients, particularly folate, vitamin B-12, iron, and zinc, to ensure the Dietary Reference Intakes (DRI) are met. Research indicates that pregnant vegetarians did not meet dietary requirements for at least one of these micronutrients. Two high quality studies report that pregnant vegetarians had significantly lower serum B-12 concentrations than pregnant non-vegetarians. In addition, research studies measuring MMA levels showed that the prevalence of vitamin B-12 deficiency among healthy, non-pregnant adult vegetarians ranged from 30% to 86%. When vegans and LOV/LV were analyzed separately, vegans had even higher proportions of vitamin B-12 deficiency (43% to 88%).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Conditional&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Macronutrient Needs in Pregnant Adolescent and Adult Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For pregnant adolescent and adult vegetarians and vegans, the RD should assess for adequate protein from a variety of complementary mixtures of plant proteins consumed throughout the day, compared to the DRI in pregnancy. While research indicates that pregnant vegetarians typically had lower protein intake than pregnant omnivores, they met or exceeded the national standards for protein intake for pregnant women in the populations studied.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Assessing Essential Fatty Acid Intake of Pregnant Adolescent and Adult Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For pregnant adolescent and adult vegetarians, the RD should assess dietary intake of EFA. Some research suggests that blood and tissue EPA and DHA levels may be sub-optimal among patients who follow a vegetarian dietary pattern.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Consensus&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades I, III, and Consensus&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Dietary and Micronutrient Intake of Vegetarian Children and Adolescents&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Micronutrient Intake of Adolescent Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adolescent vegetarians, the RD should specifically plan foods rich in micronutrients, such as iron, zinc, vitamin C and vitamin B-12, into the diet to meet the DRI. When appropriate, vitamin and/or mineral supplements may be indicated to prevent or resolve nutrient deficiency. Research from a limited number of Western countries showed that adolescent vegetarians or semi-vegetarians (11 to 19 years) may have lower intake than national standards for micronutrients such as iron, zinc and vitamin C. In addition, two studies measuring MMA levels showed that LOV/LV or omnivorous adolescents (9 to 15 years) who had followed a very restrictive vegetarian diet (macrobiotic) early in life may be at risk for vitamin B-12 deficiency (41% of adolescents had MMA &amp;gt;290nmol/L and 21% had MMA &amp;gt;410nmol/L).Fair, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Fair&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Dietary Intake of Adolescent Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adolescent vegetarians, the RD should recommend a meal plan that incorporates foods rich in calcium (e.g., dairy products, kale, broccoli, fortified soy milk, etc.) or if appropriate, calcium supplements. Research indicates that although dietary patterns differ, adolescent vegetarians (11 to 19 years) tended to consume fewer dairy products.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Micronutrient Intake of Vegetarian Children&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For vegetarian children, the RD should design a nutrition prescription to ensure the DRI for all micronutrients, particularly vitamin B-12, are met. If appropriate, vitamin and/or mineral supplements may be needed to prevent or resolve nutrient deficiency. Research studies measuring MMA levels indicate that small children (10 months to 11.7 years) of parents who follow a macrobiotic diet had a high prevalence of vitamin B-12 deficiency (55% to 85%).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Weak&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades II and III&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Diet Diversity and Vegetarian Diets for Children, Adolescents and Adults&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Diet Diversity of Vegetarian Diets for Children, Adolescents and Adults&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;If the adult, child or adolescent patient or client is on a highly restrictive vegetarian diet with a narrow range of food choices, then the RD should educate them on the importance of including a variety of foods within their diet to meet their nutritional needs. When appropriate, vitamin and/or mineral supplements may be indicated. Research shows that vegetarian dietary patterns vary and fluctuate over time. Even within types of vegetarian diets, individuals vary in the extent to which they include a variety of plant-based foods. Vegetarians who are on highly restrictive diets resulting from unhealthful food choices may be at nutritional risk.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Conditional&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades I and II&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Macronutrient Intake of Adult, Child and Adolescent Vegetarians&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN Protein Intake of Adult, Child and Adolescent Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adult, child and adolescent vegetarians, the RD should develop a nutrition prescription providing adequate protein, and offer comprehensive nutrition education and skill development on planning a diet which provides a variety of protein foods. While meeting protein requirements is typically not an issue with vegetarian diets, the RD can recommend including complementary mixtures of plant proteins. This can be achieved by consuming a varied diet throughout the day.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Consensus&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Essential Fatty Acid Intake of Adult, Child and Adolescent Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In the adult, child or adolescent vegetarian, if nutrition assessment of intake or blood levels of EPA and DHA reveals a potential deficiency or lower than optimal levels, the RD should counsel the patient or client to increase EPA and DHA levels by any of the following methods (as appropriate based on RD clinical judgment):&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Increasing intake of foods rich in EPA and DHA &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;EPA and DHA supplementation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Increase endogenous synthesis of EFA by decreasing intake of omega-6 fatty acid as well as reducing the amount of saturated fat and trans fat in the diet &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Consensus&lt;/strong&gt;, Conditional&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are based on &lt;strong&gt;Consensus&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Micronutrient Intake of Adult Vegetarians&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Micronutrient Intake of Adult Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adult vegetarian patients or clients, the RD should design a nutrition prescription to ensure the DRI for all micronutrients, particularly vitamin B-12, are met. When appropriate, vitamin and/or mineral supplements may be indicated to prevent or resolve nutrient deficiency. Research studies measuring MMA levels showed that the prevalence of B-12 deficiency among healthy, non-pregnant adult vegetarians ranged from 30% to 86%. When vegans and LOV/LV were analyzed separately, vegans had even higher proportions of vitamin B-12 deficiency (43% to 88%). Among older adults (&amp;gt;55 years), the prevalence of vitamin B-12 deficiency was 46.9% to 68%.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Fair&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades I and III&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Nutrition Counseling to Support a Therapeutic Vegetarian Diet for Adults&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Nutrition Counseling to Support Therapeutic Vegetarian Diets for Adults&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;If a vegetarian diet is proposed as a therapeutic diet according to stage in the life cycle and disease state for adults, the RD should employ a variety of counseling approaches and strategies to promote adherence to the diet. Research shows that intensive support (e.g., frequent encounters, cooking demonstration, incentives, etc.) can improve nutrition-related outcomes when using a vegetarian diet therapeutically and nutrition counseling strategies such as motivational interviewing can improve adherence to recommendations and diet-related outcomes.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Conditional&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades I, II, and III&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Macronutrient Intake of Adolescent and Adult Vegetarians During Pregnancy&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Protein Intake of Pregnant Adolescent and Adult Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For pregnant adult and adolescent vegetarians and vegans, the RD should develop a nutrition prescription and offer comprehensive nutrition education and skill development on planning a diet which provides adequate protein from a variety of complementary mixtures of plant proteins consumed throughout the day. While research indicates that pregnant vegetarians typically had lower protein intake than pregnant omnivores, they met or exceeded the national standards for protein intake for pregnant women in the populations studied.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Weak&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Essential Fatty Acid Intake of Pregnant Adolescent and Adult Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For the pregnant adolescent or adult vegetarian, if nutrition assessment of intake or blood levels of EPA and DHA reveals a potential deficiency or lower than optimal levels, the RD should counsel the patient or client to increase EPA and DHA levels by any of the following methods (as appropriate based on RD clinical judgment):&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Increasing intake of foods rich in EPA and DHA &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;EPA and DHA supplementation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Increase endogenous synthesis of essential fatty acids (EFA) by decreasing intake of omega-6 fatty acid as well as reducing the amount of saturated fat and trans fat in the diet &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Consensus&lt;/strong&gt;, Conditional&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grade III and Consensus&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Micronutrient Intake in Adolescent and Adult Vegetarians During Pregnancy&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Micronutrient Intake in Pregnant Adolescent and Adult Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For pregnant adolescent and adult vegetarians, the RD should design a nutrition prescription to ensure the DRI for all micronutrients are met. If unable to meet the DRI for recommended levels of micronutrients, particularly iron, folate and zinc, the RD should recommend supplementation to ensure adequate intake. Research indicates that pregnant vegetarians did not meet dietary requirements for at least one of these micronutrients.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Fair&lt;/strong&gt;, Conditional&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Vitamin B-12 Intake in Pregnant Adolescent and Adult Vegetarians&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For pregnant adolescent and adult vegetarian or vegan patients or clients, the RD should design a nutrition prescription to ensure vitamin B-12 requirements are met by diet and/or supplementation, including prenatal supplements. Two high quality studies report that lacto-ovo vegetarian pregnant women are less likely than non-vegetarian pregnant women to meet dietary requirements for vitamin B-12 intake, and two high quality studies report that pregnant vegetarians had significantly lower serum B-12 concentrations than pregnant non-vegetarians. In addition, twelve studies measuring MMA levels showed that the prevalence of vitamin B-12 deficiency among healthy, non-pregnant adult vegetarians ranged from 30% to 86%. When vegans and LOV/LV were analyzed separately, vegans had even higher proportions of vitamin B-12 deficiency (43% to 88%).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Fair&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades I and III&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Hyperlipidemia Treatment with a Vegetarian Diet for Adults&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Treating Hyperlipidemia with a Vegetarian Diet for Adults&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;If consistent with patient or client preference, the RD may recommend and educate on the benefits of a vegetarian diet for adults seeking treatment to lower total cholesterol (TC) and low-density lipoprotein-cholesterol (LDL-C) levels, or if appropriate, to reduce weight. Research shows that various types of vegetarian diets (e.g., vegetarian Ornish, Portfolio diet, ovo-lacto vegetarian and vegan) lower TC from 7.2% to 26.6% and lower LDL-C from 8.7% to 35% (with five of the eight studies that provided comparison data showing a decrease between 10% and 20% for both TC and LDL-C). Vegan diets lower both TC and LDL-C more than other types of vegetarian diets.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Conditional&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statement is &lt;strong&gt;Grade I&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Overweight and Obesity Treatment with a Vegetarian Diet for Adults&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Treating Overweight and Obesity with a Vegetarian Diet for Adults&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;If consistent with patient or client preference, the RD may recommend and educate on the benefits of the therapeutic use of a vegetarian diet for adults seeking treatment for overweight or obesity. Research indicates that the therapeutic use of a vegetarian diet is effective for treating overweight and obesity in both the short term (less than one year) and longer term (greater than one year), and may perform better than alternative omnivorous diets for the same purpose. Percent weight loss ranged from 3.2% to 9.3% at 12 months across studies.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Conditional&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades I and III&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Type 2 Diabetes Treatment with a Vegetarian Diet for Adults&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Treating Type 2 Diabetes with a Vegetarian Diet for Adults&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;If consistent with patient or client preference, the RD may recommend and educate on the benefits of the therapeutic use of a vegetarian diet for adults seeking treatment for type 2 diabetes. Research indicates that a vegetarian diet may decrease or maintain blood glucose levels; a vegan diet may decrease hemoglobin A1c (A1c) as well as, or better than, an omnivorous diet. Additionally, a vegetarian diet may reduce diabetes-related co-morbidities (e.g., cardiovascular disease, obesity, and hypertension).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Fair&lt;/strong&gt;, Conditional&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades II and III&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;VN: Monitoring Adherence to Vegetarian Diet Prescriptions for Adults&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Adherence to a Vegetarian Therapeutic Diet for Adults&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adult patients or clients, the RD should monitor and evaluate adherence to a therapeutic vegetarian diet. Research indicates that these diets appear to perform as well and possibly better than omnivorous diets in terms of attrition rate, provided that patients receive nutrition education and appropriate dietary support. Many factors may influence the adherence to a diet, such as disease state, length of intervention, restrictiveness, and patient support.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;VN: Adherence to Vegetarian Diets for Treatment of Obesity and Overweight for Adults&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For adult patients or clients seeking treatment for overweight or obesity with a vegetarian diet, the RD should monitor and evaluate adherence and provide continued nutrition education support. Research shows lower compliance rates for weight loss patients versus patients treated for other disease states.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statement is &lt;strong&gt;Grade I&lt;/strong&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Definitions&lt;/strong&gt;&lt;/span&gt;:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Conditional versus Imperative Recommendations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Recommendations can be worded as &lt;strong&gt;conditional&lt;/strong&gt; or &lt;strong&gt;imperative&lt;/strong&gt; statements. Conditional statements clearly define a specific situation, while imperative statements are broadly applicable to the target population without restraints on their pertinence. More specifically, a conditional recommendation can be stated in if/then terminology (e.g., if an individual does not eat food sources of omega-3 fatty acids, then 1 g of EPA and DHA omega-3 fatty acid supplements may be recommended for secondary prevention).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In contrast, imperative recommendations &quot;require,&quot; or &quot;must,&quot; or &quot;should achieve certain goals,&quot; but do not contain conditional text that would limit their applicability to specified circumstances (e.g., portion control should be included as part of a comprehensive weight management program. Portion control at meals and snacks results in reduced energy intake and weight loss).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Conclusion Grading Table&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Conclusion Grading Table&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Strength of Evidence Elements&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade I&lt;br /&gt;&#xD;&#xA;            Good/Strong&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade II&lt;br /&gt;&#xD;&#xA;            Fair&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade III&lt;br /&gt;&#xD;&#xA;            Limited/Weak&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade IV&lt;br /&gt;&#xD;&#xA;            Expert Opinion Only&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade V&lt;br /&gt;&#xD;&#xA;            Grade Not Assignable&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Quality&lt;/strong&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Scientific rigor/validity &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Considers design and execution &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studies of strong design for question&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Free from design flaws, bias and execution problems &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studies of strong design for question with minor methodological concerns&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Only studies of weaker study design for question&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studies of weak design for answering the question&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Inconclusive findings due to design flaws, bias or execution problems&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;No studies available&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Conclusion based on usual practice, expert consensus, clinical experience, opinion, or extrapolation from basic research &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;No evidence that pertains to question being addressed &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Consistency&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Of findings across studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Findings generally consistent in direction and size of effect or degree of association, and statistical significance with minor exceptions at most&lt;/td&gt;&#xD;&#xA;            &lt;td style=&quot;text-align: left; vertical-align: top;&quot;&gt;Inconsistency among results of studies with strong design&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Consistency with minor exceptions across studies of weaker designs&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Unexplained inconsistency among results from different studies&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Single study unconfirmed by other studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Conclusion supported solely by statements of informed nutrition or medical commentators&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;NA&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Quantity&lt;/strong&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Number of studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Number of subjects in studies &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;One to several good quality studies&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Large number of subjects studied&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Studies with negative results having sufficiently large sample size for adequate statistical power&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Several studies by independent investigators&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Doubts about adequacy of sample size to avoid Type I and Type II error &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Limited number of studies&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Low number of subjects studied and/or inadequate sample size within studies &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Unsubstantiated by published studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Relevant studies have not been done&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Clinical Impact&lt;/strong&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Importance of studied outcomes &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Magnitude of effect &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studied outcome relates directly to the question&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Size of effect is clinically meaningful&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Significant (statistical) difference is large &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Some doubt about the statistical or clinical significance of effect&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studied outcome is an intermediate outcome or surrogate for the true outcome of interest&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Size of effect is small or lacks statistical and/or clinical significance&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Objective data unavailable&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Indicates area for future research&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Generalizability&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            To population of interest&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studied population, intervention and outcomes are free from serious doubts about generalizability&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Minor doubts about generalizability&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Serious doubts about generalizability due to narrow or different study population, intervention or outcomes studied&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Generalizability limited to scope of experience&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;NA&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;This grading system was based on the grading system from Greer, Mosser, Logan, &amp;amp; Wagstrom Halaas. A practical approach to evidence grading. Jt Comm J Qual Improv. 2000;26:700-712. &lt;a href=&quot;http://www.adaevidencelibrary.com/topic.cfm?cat=1330&quot; title=&quot;AND Web site&quot;&gt;http://www.adaevidencelibrary.com/topic.cfm?cat=1330&lt;/a&gt;. In September 2004, The ADA Research Committee modified the grading system to this current version.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Criteria for Recommendation Rating&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Criteria for Recommendation Rating&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Statement Rating&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Definition&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Implication for Practice&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Strong&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Strong&lt;/strong&gt; recommendation means that the workgroup believes that the benefits of the recommended approach clearly exceed the harms (or that the harms clearly exceed the benefits in the case of a strong negative recommendation), and that the quality of the supporting evidence is excellent/good (grade I or II).* In some clearly identified circumstances, strong recommendations may be made based on lesser evidence when high-quality evidence is impossible to obtain and the anticipated benefits strongly outweigh the harms. &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should follow a &lt;strong&gt;Strong&lt;/strong&gt; recommendation unless a clear and compelling rationale for an alternative approach is present. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Fair&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Fair&lt;/strong&gt; recommendation means that the workgroup believes that the benefits exceed the harms (or that the harms clearly exceed the benefits in the case of a negative recommendation), but the quality of evidence is not as strong (grade II or III).* In some clearly identified circumstances, recommendations may be made based on lesser evidence when high-quality evidence is impossible to obtain and the anticipated benefits outweigh the harms.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should generally follow a &lt;strong&gt;Fair&lt;/strong&gt; recommendation but remain alert to new information and be sensitive to patient preferences.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Weak&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Weak&lt;/strong&gt; recommendation means that the quality of evidence that exists is suspect or that well-done studies (grade I, II, or III)* show little clear advantage to one approach versus another.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should be cautious in deciding whether to follow a recommendation classified as &lt;strong&gt;Weak&lt;/strong&gt;, and should exercise judgment and be alert to emerging publications that report evidence. Patient preference should have a substantial influencing role. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Consensus&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Consensus&lt;/strong&gt; recommendation means that Expert opinion (grade IV) supports the guideline recommendation even though the available scientific evidence did not present consistent results, or controlled trials were lacking.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should be flexible in deciding whether to follow a recommendation classified as &lt;strong&gt;Consensus&lt;/strong&gt;, although they may set boundaries on alternatives. Patient preference should have a substantial influencing role. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Insufficient Evidence&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;An &lt;strong&gt;Insufficient Evidence&lt;/strong&gt; recommendation means that there is both a lack of pertinent evidence (grade V)* and/or an unclear balance between benefits and harms.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should feel little constraint in deciding whether to follow a recommendation labeled as &lt;strong&gt;Insufficient Evidence&lt;/strong&gt; and should exercise judgment and be alert to emerging publications that report evidence that clarifies the balance of benefit versus harm. Patient preference should have a substantial influencing role.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*Conclusion statements are assigned a grade based on the strength of the evidence. Grade I is good; grade II, fair; grade III, limited; grade IV signifies expert opinion only and grade V indicates that a grade is not assignable because there is no evidence to support or refute the conclusion. The evidence and these grades are considered when assigning a rating (Strong, Fair, Weak, Consensus, Insufficient Evidence - see chart above) to a recommendation.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Adapted by the Academy of Nutrition and Dietetics (AND) from the American Academy of Pediatrics, Classifying Recommendations for Clinical Practice Guideline, Pediatrics. 2004;114;874-877. Revised by the AND Evidence-Based Practice Committee, Feb 2006.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following algorithms are provided in the original guideline document:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Vegetarian Nutrition (VN) Algorithm &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;VN Nutrition Assessment &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;VN Nutrition Diagnosis &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;VN Nutrition Intervention &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;VN Monitoring and Evaluation &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of supporting evidence is identified and graded for each recommendation (see the &quot;Major Recommendations&quot; field).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The guideline contains conclusion statements that are supported by evidence summaries and evidence worksheets. These resources summarize the important studies (randomized controlled trials [RCTs], clinical trials, observational studies, cohort and case-control studies) pertaining to the conclusion statement and provide the study details.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;A primary goal of implementing these recommendations includes improving a person's ability to achieve optimal nutrition through healthful plant-based food choices and a physically active lifestyle. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Although costs of medical nutrition therapy (MNT) sessions and reimbursement vary, MNT is essential for improved outcomes. MNT education can be considered cost effective when considering the benefits of nutrition interventions on the onset and progression of comorbidities versus the cost of the intervention. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Overall Risk/Harm Considerations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Safety issues must be reviewed carefully for each individual. General benefits and risks associated with implementation of the guideline are addressed for each recommendation.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation-Specific Risks/Harms&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Calcium Supplements&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Some individuals who take calcium supplements, particularly calcium carbonate, might experience gastrointestinal side effects including gas, bloating, and/or constipation. To alleviate these symptoms, consideration for another form of calcium may be warranted, as well as spreading out the calcium dose throughout the day and/or taking the supplement with meals.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Vitamin B-12 Intake in Pregnant Adolescent and Adult Vegetarians&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Care should be taken that pregnant patient or client intake from all sources is not above the tolerable upper intake level (UL). Supplementation is only encouraged after assessment of dietary intake and supplementation intake.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In addition to the above, a variety of barriers may hinder the application of these recommendations:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;A vegetarian dietary pattern encompasses wide variations in foods eaten and complexity regarding dietary practices, beliefs and motivations. The registered dietitian (RD) should maintain flexibility and acceptance to support the lifestyle choices in working with this population. (See the Guideline Overview in the original guideline document for a more detailed explanation of the complexity of vegetarian dietary patterns). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;In some cases, there may be increased cost associated with the selective use of vitamin and mineral supplements &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Accessibility and costs of biochemical parameter testing should be considered. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field></Section><Section SecID="430" OrdBy="800" Name="Contraindications"><Field FieldID="144" OrdBy="805" ID="431" Name="Contraindications" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Since the optimal ratio of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are not known for vegetarians, very high levels of EPA and DHA may be contraindicated, and thus, over-supplementation should be avoided. The US Food and Drug Administration advises that consumption of more than three grams of omega-3 fatty acids per day may cause gastrointestinal symptoms.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;While the evidence-based nutrition practice guideline represents a statement of best practice based on the latest available evidence at the time of publication, the guideline is not intended to overrule professional judgment. Rather, it may be viewed as a relative constraint on individual clinician discretion in a particular clinical circumstance. The independent skill and judgment of the health care provider must always dictate treatment decisions. These nutrition practice guidelines are provided with the express understanding that they do not establish or specify particular standards of care, whether legal, medical or other. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;This nutrition practice guideline is meant to serve as a general framework for handling clients with particular health problems. It may not always be appropriate to use these nutrition practice guidelines to manage clients because individual circumstances may vary. For example, different treatments may be appropriate for clients who are severely ill or who have co-morbid, socioeconomic, or other complicating conditions. The independent skill and judgment of the health care provider must always dictate treatment decisions. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This publication of this guideline is an integral part of the plans for getting the Academy of Nutrition and Dietetics medical nutrition therapy (MNT) evidence-based recommendations for vegetarian nutrition to all dietetics practitioners engaged in, teaching about or researching the topic. National implementation workshops at various sites around the country and during the Academy's Food Nutrition Conference Expo (FNCE) are planned. Additionally, there are recommended dissemination and adoption strategies for local use.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The guideline development team recommended multi-faceted strategies to disseminate the guideline and encourage its implementation. Management support and learning through social influence are likely to be effective in implementing guidelines in dietetic practice. However, additional interventions may be needed to achieve real change in practice routines.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Implementation of the guideline will be achieved by announcement at professional events, presentations and training. Some strategies include:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;National and Local Events&lt;/strong&gt; &amp;ndash; State dietetic association meetings and media coverage will help launch the guideline &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Local Feedback Adaptation&lt;/strong&gt; &amp;ndash; Presentation by members of the work group at peer review meetings and opportunities for continuing professional education unites (CEUs) for courses completed &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Education Initiatives&lt;/strong&gt; &amp;ndash; The guideline and supplementary resources will be freely available for use in the education and training of dietetic interns and students in approved Commission on Accreditation of Dietetics Education (CADE) programs &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Champions&lt;/strong&gt; &amp;ndash; Local champions will be identified and expert members of the guideline team will prepare articles for publications. Resources will be provided that include PowerPoint presentations, full guidelines and pre-prepared case studies. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Practical Tools&lt;/strong&gt; &amp;ndash; Some of the tools that will be developed to help implement the guideline include specially designed resources, such as clinical algorithms, slide presentations, training and toolkits. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Specific distribution strategies include:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Publication in full&lt;/em&gt;: The guideline is available electronically at the Academy Evidence Analysis Library website (&lt;a href=&quot;http://www.adaevidencelibrary.com&quot; title=&quot;AND Web site&quot;&gt;www.adaevidencelibrary.com&lt;/a&gt;) and announced to all Academy Dietetic Practice Groups. The Academy Evidence Analysis Library will also provide downloadable supporting information and links to relevant position papers.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Clinical Algorithm" /><FieldValue Value="Patient Resources" /><FieldValue Value="Quick Reference Guides/Physician Guides" /><FieldValue Value="Resources" /><FieldValue Value="Slide Presentation" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Getting Better" /><FieldValue Value="Staying Healthy" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Academy of Nutrition and Dietetics. Vegetarian nutrition (VN) evidence based nutrition guideline. Chicago (IL): Academy of Nutrition and Dietetics; 2011 Sep. Various p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2011 Sep" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Academy of Nutrition and Dietetics - Professional Association" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Academy of Nutrition and Dietetics&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The Vegetarian Nutrition Workgroup&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Workgroup Members&lt;/em&gt;: Sudha Raj, PhD, RD (&lt;em&gt;Chair&lt;/em&gt;); Amy Knoblock-Hahn, RD, LD; Diana K. Cullum-Dugan, RD, LD; Debbie Lucus, MS, RD, CDE; Kimberly J. Thedford, MS, RD, LD; Roman M. Pawlak, PhD, RD&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;In the interest of full disclosure, the Academy has adopted the policy of revealing relationships workgroup members have with companies that sell products or services that are relevant to this guideline topic. Workgroup members are required to disclose potential conflicts of interest by completing the Academy Conflict of Interest Form. It should not be assumed that these financial interests will have an adverse impact on the content of the guideline, but they are noted here to fully inform readers.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;None of the workgroup members disclosed potential conflicts of interest.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: Available to members from the &lt;a href=&quot;http://www.adaevidencelibrary.com/&quot; title=&quot;AND Web site&quot;&gt;Academy of Nutrition and Dietetics Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Academy of Nutrition and Dietetics vegetarian nutrition evidence-based nutrition practice guideline. Executive summary of recommendations. 2011. Chicago (IL): Academy of Nutrition and dietetics. Electronic copies: Available from the &lt;a href=&quot;http://www.adaevidencelibrary.com/topic.cfm?cat=4022&quot; title=&quot;Academy of Nutrition and Dietetics Web site&quot;&gt;Academy of Nutrition and Dietetics Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Academy of Nutrition and Dietetics vegetarian nutrition evidence-based nutrition practice guideline presentation. Slide set. 2011. 67 p. Chicago (IL): American Dietetic Association. Electronic copies: Available for purchase from the &lt;a href=&quot;https://www.adaevidencelibrary.com/store.cfm?category=5&quot; title=&quot;Academy of Nutrition and Dietetics Web site&quot;&gt;Academy of Nutrition and Dietetics Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;In addition, various resources for estimating and testing resting metabolic rate are available in the appendices to the original guideline document.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Patient/client instructions for measuring resting metabolism are available in the appendices to the original guideline document.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Disclaimer&quot;&gt;Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI Institute on April 4, 2012.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The Academy of Nutrition and Dietetics encourages the free exchange of evidence in nutrition practice guidelines and promotes the adaptation of the guidelines for local conditions. However, please note that guidelines are subject to copyright provisions. To replicate or reproduce this guideline, in part or in full, please obtain agreement from the Academy of Nutrition and Dietetics. Please contact Kari Kren at &lt;a href=&quot;mailto:kkren@eatright.org&quot;&gt;kkren@eatright.org&lt;/a&gt; for copyright permission.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;When modifying the guidelines for local circumstances, significant departures from these comprehensive guidelines should be fully documented and the reasons for the differences explicitly detailed.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
